Shoeshine: Will F&P Healthcare hit Trump's wall?
NZ-listed company faces a Tijuana challenge — but one analyst says it's underpriced regardless.
Fisher & Paykel Healthcare is not a glamorous company. It is never going to impress people with its beautiful products, slick marketing campaigns or its quick flight to success.
It makes useful things, lifesaving things; masks to help people breathe more easily, either in hospital through its
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Shoeshine
Sat, 19 Nov 2016
Sat, 19 Nov 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Shoeshine: Will F&P Healthcare hit Trump's wall?
Shoeshine,
63205